In consequence, we interested in whether low expression of miR‐508‐3p promotes PASMC proliferation leading to PAH by activating MEK signalling, which is well established to advance the pathogenesis of PAH. This evidence concerns the gene MAP2K7 and pulmonary arterial hypertension.